Jafron Biomedical, a leading enterprise in the hemoadsorption industry recently announces that Mr. Jean Paul Menneguerre, global expert in the acute blood purification area for more than 30 years, has joined Jafron Biomedical as Global Senior Consultant since January 2021.

As global senior consultant, Mr. Menneguerre is mainly responsible for marketing strategy and clinical activities, and he will carry out his work around the Jafron's long-term goal of building "world-class high-tech medical technology enterprise", and play a role in Jafron at the strategic height of sustainable development.

"Jafron is the biggest provider for full line of adsorption therapies. Their HA and BS series hemoperfusion cartridges have been validated by various institutes and experts. As one of the key roles in the coming Multi-Organ Support Therapy (MOST), adsorption therapy has a huge potential market in the intensive care and other medical fields. Therefore, I am very confident about the future of Jafron", said Mr. Menneguerre, who had held senior positions in several giant companies of blood purification in the past 30 years, such as B. Braun Avitum, Baxter, Edwards and Hospal RIC. 

Mr. Dong Fan, founder and chairman of Jafron states , "With Mr. Menneguerre's support, who has rich experience in blood purification industry, Jafron will gain reliable marketing knowledge as well as successful experience in the Extracorporeal Organ Support (ECOS) field."

It is reported that Jafron's hemoperfusion products have been applied in more than 6000 hospitals, 75 countries with over 3 million cases worldwide annually. As an A-shared GEM listed corporation and a pioneer enterprise in hemoadsorption industry, Jafron has been providing comprehensive solutions with full line products including HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column since 1989 and established a multinational strategic partnership to bring cutting-edge medical products worldwide.